Showing results (221-230 of 711) with videos related to
Sort By:
Pageof 72
Pharmacology, Biochemistry, and Behavior|July 19, 2000
Nicotine blood levels and subjective craving for cigarettesM E Jarvik, D C Madsen, R E Olmstead, et al.Tobacco Control|June 4, 2004
Reducing tobacco addiction through tobacco product regulationJ E Henningfield, N L Benowitz, G N Connolly, et al.Tobacco Control|June 1, 2005
Toward a comprehensive long term nicotine policyN Gray, J E Henningfield, N L Benowitz, et al.Journal of Toxicology. Clinical Toxicology|January 1, 1993
Hydroxocobalamin as a cyanide antidote: safety, efficacy and pharmacokinetics in heavily smoking normal volunteersJ C Forsyth, P D Mueller, C E Becker, et al.Journal of Neurophysiology|September 1, 1994
Role of vagal afferents and spinal pathways modulating inhibition of bradykinin-induced plasma extravasation by intrathecal nicotineF J Miao, W Jänig, M F Dallman, et al.Clinical Pharmacology and Therapeutics|May 25, 2007
Identification of novel CYP2A6*1B variants: the CYP2A6*1B allele is associated with faster in vivo nicotine metabolismJ C Mwenifumbo, C N Lessov-Schlaggar, Q Zhou, et al.Clinical Pharmacology and Therapeutics|March 13, 2009
Association of nicotine metabolite ratio and CYP2A6 genotype with smoking cessation treatment in African-American light smokersM K Ho, J C Mwenifumbo, N Al Koudsi, et al.Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales|January 1, 1993
[Elastin: preparation, characterization, structure, biosynthesis and catabolism]M P JacobClinical Pharmacology and Therapeutics|April 16, 2014
Association of CHRNA5-A3-B4 SNP rs2036527 with smoking cessation therapy response in African-American smokersA Z X Zhu, Q Zhou, L S Cox, et al.Neuropsychologia|February 15, 2005
Visual cognition: a new look at the two-visual systems modelM Jeannerod, P JacobPageof 72